Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial Intelligence-Mediated Discharge Document for Accessible Health Care (AIM-HEALTH): Protocol for a Prospective, Observational, Noninterventional Study.

JMIR research protocols·2026
Same author

Pleiotropic effects of bempedoic acid on endothelial function and arterial stiffness: a preliminary study.

Journal of cardiovascular medicine (Hagerstown, Md.)·2026
Same author

Impact of left anterior descending lesions on 30-day mortality in very elderly STEMI patients: insights from a multicenter registry.

Journal of cardiovascular medicine (Hagerstown, Md.)·2026
Same author

Correlation Between Epicardial Adipose Tissue and PET Cardiac Perfusion: A Systematic Review.

Medical sciences (Basel, Switzerland)·2026
Same author

Relationship between epicardial adipose tissue and coronary function evaluated with [13 N]NH3 PET/CT.

The international journal of cardiovascular imaging·2026
Same author

The Role of [18F]FDG PET-Based Radiomics and Machine Learning for the Evaluation of Cardiac Sarcoidosis: A Narrative Literature Review.

Medicina (Kaunas, Lithuania)·2025

Related Experiment Video

Updated: Jul 4, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

[Peripartum cardiomyopathy].

Riccardo Raddino1, Ivano Bonadei, Melissa Teli

  • 1Sezione di Malattie Cardiovascolari, Dipartimento di Medicina Sperimentale Applicata, Università degli Studi di Brescia.

Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace
|July 3, 2008
PubMed
Summary
This summary is machine-generated.

Peripartum cardiomyopathy (PPCM) is a rare heart condition affecting women during pregnancy or after birth. Early diagnosis and treatment are crucial for recovery, though persistent cases have a poor prognosis.

More Related Videos

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

An Intact Pericardium Ischemic Rodent Model
07:15

An Intact Pericardium Ischemic Rodent Model

Published on: September 2, 2021

Related Experiment Videos

Last Updated: Jul 4, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

An Intact Pericardium Ischemic Rodent Model
07:15

An Intact Pericardium Ischemic Rodent Model

Published on: September 2, 2021

Area of Science:

  • Cardiology
  • Obstetrics
  • Genetics

Context:

  • Peripartum cardiomyopathy (PPCM) is a rare form of heart failure.
  • It affects previously healthy women during late pregnancy or postpartum.
  • Incidence varies widely, from 1 in 1300 to 15,000 pregnancies.

Purpose:

  • To define peripartum cardiomyopathy (PPCM).
  • To outline diagnostic criteria and risk factors.
  • To discuss clinical presentation, diagnosis, treatment, and prognosis.

Summary:

  • PPCM involves left ventricular dysfunction and heart failure symptoms in the peripartum period.
  • Diagnosis relies on heart failure onset, absence of other causes, and no prior heart disease.
  • Risk factors include advanced maternal age, multiparity, African race, twinning, gestational hypertension, and tocolysis.

Impact:

  • Early diagnosis and treatment are vital for optimizing pregnancy outcomes.
  • About 50% of patients recover fully.
  • Persistent cardiomyopathy after six months indicates irreversible disease and poorer survival rates.